Yi Kathy 4
4 · Theseus Pharmaceuticals, Inc. · Filed Oct 8, 2021
Insider Transaction Report
Form 4
Yi Kathy
Director
Transactions
- Award
Stock Option (right to buy)
2021-10-06+22,678→ 22,678 totalExercise: $16.00Exp: 2031-10-05→ Common Stock (22,678 underlying)
Footnotes (1)
- [F1]The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/36th of the options vesting monthly after October 6, 2021, subject to the Reporting Person's continuous service with the issuer.